Similar User
@ZainAsadEP
@HafeezHassan20
@pras_senMD
@HankJennings34
@mwaqaschoudhry
@umairsahmad
@RealJamieGold
@CJanishCardsMD
@NavinNakraMD
Release Imran Khan!
Protesters demanding the release of Pakistan’s jailed former premier Imran Khan reached the edge of the nation’s capital, authorities said late Monday night trib.al/Rg00qF9
1/ Today, we honored 🌟“Dr. Ralph Lazzara” 🌟a legend in the world of electrophysiology 🫀and former Chair of Cardiology at @OUCollegeofMed @OUHealth The Inaugral Ralph Lazzara lecture was a master class delivered by another legend @shivkumarmd @uclaCVfellows
1/ Read the ACC Emerging Faculty Leadership Academy 2024 Cohort’s Experience in @JACCJournals 1.Empowering Future Leaders 🔥 Equips cardiologists with essential leadership and teaching skills, driving excellence in patient care and education. jacc.org/doi/10.1016/j.…
Time to close out; follow images below also ✅ This is m-mode in constrictive pericarditis (CP) ✅ Septal bounce seen (yellow 🏹 below in image 1 below) ✅ Interventricular dependence seen (when RV is larger, LV is small & Vice versa). Total space for RV+ LV is constant in insp…
1/5 My Dx for the e' velocity of 4 cm/s is reduced myocardial relaxation, which is sine qua non of diastolic dysfunction. It is present in all forms of myocardial disease and also with aging. Let me explain its progression & how to use the information for our pts @MayoClinicCV
Presented at #ERA24: FLOW trial: In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. nej.md/44U3slP
A modular leadless pacemaker in wireless communication with a subcutaneous ICD was shown to be safe and exceeded performance goals for communication between the pacemaker and ICD. Full MODULAR ATP study results: nej.md/4bfXZbj
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease #AHAJournals ahajrnls.org/3WF8a4M
Presented at #HeartFailure2024: Among patients with symptomatic obstructive hypertrophic cardiomyopathy, treatment with aficamten led to a greater increase in peak oxygen consumption than placebo at 6 months. Full SEQUOIA-HCM phase 3 trial results: nej.md/3wmDzyl
🔑 Normal-flow low-gradient severe AS is defined as aortic valve area ≤1.0 cm2 w/ low gradient + normal flow and occurs in approx 20-30% of patients w/ severe AS. Read more key points from a review comparing the US & European guidelines for NFLG AS: bit.ly/3wsueF3
Original Article: Transcatheter or Surgical Treatment of Aortic-Valve Stenosis (DEDICATE-DZHK6) nej.md/3TLx8MT Editorial: Another Early Win for TAVI in Low-Risk Patients nej.md/3J5F7j5
Original Article: Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction (AEGIS-II) nej.md/3U4yxzk Editorial: HDL Therapeutics — Time for a Curtain Call or Time to Reconceptualize? nej.md/49ryYIG
Numbers you need to remember for diagnosing pulmonary artery hypertension (PAH) 🧵 • mPAP > 25 mm Hg • PCWP/PAOP < 15 mm Hg • TPG > 12 mm Hg • TRV > 3.0 m/sec • TAPSE < 16 mm • Woods unit > 3 (mPAP - PCWP/CO) • CT angio chest : PA size > 29 mm #Cardio #PulmCrit
Check out this #JACCINT state-of-the-art review discussing the contemporary assessment and management of tricuspid regurgitation bit.ly/3Jf2VRw #vhdTR #CathLab @GarrettWelleMD @EleidMack @hahn_rt
Presented today at #ACC24: A randomized trial that enrolled patients with severe aortic stenosis at low or intermediate surgical risk showed that TAVI was noninferior to SAVR at 1 year. Read the full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT
Original Article: Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome (Balance) nej.md/43QdO5W Science behind the Study: Shooting the Messenger to Treat Hypertriglyceridemia nej.md/4aKpdpQ @ACCinTouch #ACC24
Original Article: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes (STEP-HFpEF DM) nej.md/3TPKpUC @ACCinTouch #ACC24
Among patients with obesity-related heart failure with preserved ejection fraction & type 2 diabetes, semaglutide produced greater reductions in symptoms, physical limitations & body weight than placebo at 1 year. Full STEP-HFpEF DM trial results: nej.md/3TPKpUC #ACC24
Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t
United States Trends
- 1. DeSantis 35 B posts
- 2. Pete 301 B posts
- 3. Jokic 12,2 B posts
- 4. Kerr 7.204 posts
- 5. Mavs 12,4 B posts
- 6. Podz 3.338 posts
- 7. Clemson 25,1 B posts
- 8. Brea 2.625 posts
- 9. Nuggets 16,9 B posts
- 10. Jamal Murray 1.506 posts
- 11. Wiggins 2.779 posts
- 12. Kentucky 19,2 B posts
- 13. Marcus Smart 2.666 posts
- 14. azealia 4.005 posts
- 15. NBA Cup 15,2 B posts
- 16. Kuminga 2.330 posts
- 17. Grizzlies 6.324 posts
- 18. #MFFL 4.096 posts
- 19. Knicks 15,9 B posts
- 20. XDefiant 17,7 B posts
Who to follow
-
Zain Asad, MD, MS, FACC FAHA
@ZainAsadEP -
Hafeez Hassan, MD RPVI FACC FSCAI
@HafeezHassan20 -
Prasanna Sengodan
@pras_senMD -
Hank Jennings
@HankJennings34 -
M. Waqas Choudhry
@mwaqaschoudhry -
Umair S. Ahmad, MD
@umairsahmad -
Jamie Gold
@RealJamieGold -
Christopher Janish
@CJanishCardsMD -
Navin Nakra
@NavinNakraMD
Something went wrong.
Something went wrong.